{"filing":{"accession_number":"0001193125-26-231083","cik":"0001585608","ticker":null,"company_name":"Jaguar Health, Inc.","form":"8-K","filing_date":"2026-05-19","report_date":null,"primary_document":"d227929d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526231083/d227929d8k.htm"},"classifications":[{"id":193,"accession_number":"0001193125-26-231083","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The Company entered into three exchange agreements on May 19, 2026, exchanging approximately $22.7 million in aggregate royalty interest reductions for 908 shares of Series Q Perpetual Preferred Stock. This represents a material restructuring of the Company's debt obligations through conversion into equity, which affects the capital structure and is disclosed under Item 1.01 (Material Definitive Agreements). While not a traditional M\u0026A transaction, the scale and nature of the debt-for-equity exchange constitutes a material capital transaction affecting investor assessment of the registrant's financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-20T02:21:13.336400+00:00","company_name":"Jaguar Health, Inc.","ticker":null,"filing_date":"2026-05-19"},{"id":194,"accession_number":"0001193125-26-231083","item_number":"2.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.45,"reasoning":"Item 2.03 discloses creation of a direct financial obligation by incorporating Item 1.01 by reference. Without access to Item 1.01's content, the specific nature of the obligation cannot be determined. The incorporation suggests a material financial event (likely M\u0026A, debt issuance, or similar), but the actual event type cannot be reliably classified without seeing the underlying Item 1.01 disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-20T02:21:13.336400+00:00","company_name":"Jaguar Health, Inc.","ticker":null,"filing_date":"2026-05-19"},{"id":195,"accession_number":"0001193125-26-231083","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Item 3.02 explicitly discloses unregistered sales of equity securities—Common Exchange Shares and Series Q Preferred Stock—issued under Section 3(a)(9) of the Securities Act. This is a classic dilutive issuance event. The incorporation by reference to Item 1.01 suggests a material transaction (likely a debt conversion or exchange), and the use of the Section 3(a)(9) exemption is typical for private equity issuances that signal cash-raising or restructuring activity.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-20T02:21:13.336400+00:00","company_name":"Jaguar Health, Inc.","ticker":null,"filing_date":"2026-05-19"},{"id":196,"accession_number":"0001193125-26-231083","item_number":"5.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"This Item 5.03 discloses the filing of a Certificate of Designation for Series Q Preferred Stock in connection with royalty interest exchange transactions (referenced under Items 1.01 and 3.02). While the primary event is the issuance of preferred stock with complex terms (10% annual preferred return, liquidation preferences, voting rights with a 9.99% cap, and company exchange rights), the Item 5.03 classification itself is administrative. However, the underlying transaction—issuance of 2,000 shares of preferred stock with substantial economic rights and a 10% accruing preferred return—is material to investors. This does not fit neatly into the specific event types (not a simple appointment, departure, or compensation arrangement), so \"other_material\" is most appropriate.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-20T02:21:13.336400+00:00","company_name":"Jaguar Health, Inc.","ticker":null,"filing_date":"2026-05-19"}]}